ArticleInternational journal of molecular sciences2017

TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.

Hidetaka Kawabata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.